Is Akebia Therapeutics, Inc. (AKBA) a Buy, Sell, or Hold?
NASDAQ : AKBA
Akebia Therapeutics, Inc.
$1.34 USD
-$0.06 (-4.29%)
- Volume
- 2.52M
- Average Volume
- 5M
- Market Capitalization
- $359.47M
- P/E Ratio
- -17.38
- Dividend Yield
- 0.00%
- Price Target
- $4.00
- Year High
- $4.04
- Year Low
- $0.82
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.40
AKBA vs. The Competition
| Properties | AKBA | CMPX | CRVS | FDMT |
|---|---|---|---|---|
| Market Cap | $359.47M | $283.49M | $1.25B | $574.52M |
| Shares Outstanding | $268.26M | $138.29M | $84.09M | $52.28M |
| P/E Ratio | -17.38 | -4.82 | -27.09 | -4.13 |
| EPS | -0.08 | -0.37 | -0.49 | -2.36 |
| Day Low | 1.34 | 2.01 | 13.9 | 10.29 |
| Day High | 1.405 | 2.12 | 15.2 | 11.28 |
| Year Low | 0.823 | 1.61 | 3.96 | 4.145 |
| Year High | 4.04 | 6.88 | 26.95 | 14 |
| Average Price 50 | 1.11904 | 2.0792 | 13.4163 | 10.3457 |
| Average Price 200 | 1.55314 | 4.30465 | 12.6423 | 9.69393 |
| Volume | 2.52M | 2.13M | 773.27K | 578.17K |
| Average Volume | - | - | - | - |